
LENZ
LENZ Therapeutics Inc.
$18.14
-$6.36(-25.96%)
44
Overall
60
Value
30
Tech
42
Quality
Market Cap
$744.08M
Volume
6.63M
52W Range
$15.70 - $50.40
Target Price
$52.57
Company Overview
| Mkt Cap | $744.08M | Price | $18.14 |
| Volume | 6.63M | Change | -25.96% |
| P/E Ratio | -15.0 | Open | $24.66 |
| Revenue | -- | Prev Close | $24.50 |
| Net Income | $-49.8M | 52W Range | $15.70 - $50.40 |
| Div Yield | N/A | Target | $52.57 |
| Overall | 44 | Value | 60 |
| Quality | 42 | Technical | 30 |
No chart data available
Latest News
LENZ Therapeutics Responds to FDA Adverse Event Report
TipRanks Auto-Generated Newsdesk•a day ago
LENZ Therapeutics (LENZ) Receives a Buy from Citi
TipRanks Auto-Generated Intelligence Newsdesk•6 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LENZ | $18.14 | -26.0% | 6.63M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |